Dr. Chandran Gnanamuthu

National & International Awards

• Information not publicly available.

Professional Memberships

• Indian Society of Medical & Paediatric Oncology (ISMPO)
• Indian Cooperative Oncology Network (ICON)
• Indian Medical Association (IMA)

Published Papers (Selected)

• Information not publicly available.

Ongoing Research & Clinical Interests

• Chemotherapy outcomes in advanced solid tumours
• Targeted therapy in lung and breast cancer
• Supportive care and palliative oncology protocols

A patient with stage III non-small-cell lung cancer presenting with poor performance status was successfully managed with a tailored immunotherapy regimen under Dr. Naik's supervision, achieving partial remission and significant improvement in quality of life within three months.

A patient with locally advanced breast cancer underwent neoadjuvant chemotherapy under Dr. Naik's protocol, achieving pathological complete response prior to surgery — reducing disease burden by over 80% and enabling breast-conserving surgery.

• Compassionate Cancer Care: Patients consistently describe Dr. Naik as a doctor who takes time to fully explain their cancer diagnosis and treatment plan, reducing anxiety in a difficult time.
• Personalised Treatment Planning: Reviewers highlight his thorough evaluation of each case before recommending treatment, avoiding one-size-fits-all protocols.
• Reliable Follow-up: Patients note his accessible follow-up approach and quick responsiveness to side-effect concerns during active chemotherapy cycles.

Patient-Centred Care

Dr. R T S Naik takes a holistic, patient-first approach to oncology. He dedicates extended consultation time to ensure patients and families fully understand their diagnosis, staging, and treatment options. He practices shared decision-making — presenting all available treatment lines, their benefits, and their expected side-effect profiles before arriving at a plan the patient is comfortable with. Follow-up is proactive, with clear guidance on monitoring response and managing treatment-related symptoms.

Technology & Innovation

Dr. Naik employs the full spectrum of modern systemic oncology tools including IV and oral chemotherapy regimens, targeted molecular therapies (EGFR, HER2, ALK inhibitors), and immunotherapy checkpoint inhibitors. He uses molecular tumour profiling and biomarker testing to guide treatment selection, and collaborates within Apollo's multidisciplinary tumour board to ensure every patient benefits from integrated surgical, radiological, and medical oncology expertise.

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Language Support

English and Hindi are spoken; Cancer Rounds provides certified interpreters for all major international languages on request.

Visa & Travel Assistance

Cancer Rounds provides medical visa invitation letters, airport transfers, and local accommodation coordination for international patients seeking treatment from Dr. R T S Naik.

Virtual Consultations

Pre-travel video consultations are available through Cancer Rounds, allowing patients to share medical records and discuss treatment plans with Dr. R T S Naik before travelling to India.